Suit Claims Fosamax Caused Problems With Leg Bones
A new lawsuit has been filed against Merck & Co. over its osteoporosis drug Fosamax. The suit claims the drug caused a Connecticut woman to suffer multiple stress fractures in her legs as well as suppressed bone regeneration.
Merck is already facing hundreds of Fosamax lawsuits claiming the drug caused a rare and disfiguring condition known as osteonecrosis of the jaw (ONJ), or decay of the jawbone.
Fosamax is one of Merck’s top-selling drugs, generating nearly $3 billion in sales last year alone.
In November, the company announced a $4.85 settlement to cover tens of thousands of Vioxx lawsuits. Merck pulled Vioxx from the market in 2004 when evidence showed the drug caused potentially deadly heart problems.